Giapreza - direct healthcare professional communication (DHPC)

Angiotensin II acetate

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Giapreza (angiotensin II) 2.5mg/ml concentrate for solution for infusion: potentially low fill vials and important information regarding instructions for use

Dissemination date: 23/05/2024

Key facts

• Medicine name:
  Giapreza
• Active substance:
  Angiotensin II acetate
• Therapeutic area (MeSH):
  • Hypotension
  • Shock
• DHPC type:
  Quality defect
• Human ATC codes:
  C09
• Dissemination date:
  23/05/2024